ストックスクリーナーアプリを入手
404.07
1.23%
4.89
アフターアワーズ：
404.30
0.23
+0.06%
前日終値:
$399.18
開ける：
$398.57
24時間の取引高:
1.55M
Relative Volume:
0.90
時価総額：
$87.75B
収益：
$200.42B
当期純損益:
$5.24B
株価収益率:
17.19
EPS:
23.5042
ネットキャッシュフロー:
$6.45B
1週間 パフォーマンス:
-2.76%
1か月 パフォーマンス:
+2.74%
6か月 パフォーマンス:
+12.53%
1年 パフォーマンス:
+4.62%
1日の値動き範囲:
$393.35
$404.07
1週間の範囲:
$393.35
$426.98
52週間の値動き範囲:
$273.71
$426.98
Elevance Health Inc Stock (ELV) Company Profile
名前
Elevance Health Inc
セクター
電話
(800) 331-1476
住所
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
404.07 | 86.69B | 200.42B | 5.24B | 6.45B | 23.50 |
UNH
Unitedhealth Group Inc
|
408.52 | 368.30B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
101.96 | 128.21B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
298.00 | 77.99B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
379.22 | 44.27B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-08 | 開始されました | Evercore ISI | In-line |
| 2026-02-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 開始されました | Goldman | Neutral |
| 2025-07-21 | ダウングレード | Argus | Buy → Hold |
| 2025-07-18 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | アップグレード | Argus | Hold → Buy |
| 2025-01-22 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | ダウングレード | Argus | Buy → Hold |
| 2024-07-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-06-24 | 開始されました | Morgan Stanley | Overweight |
| 2024-05-30 | 開始されました | Robert W. Baird | Outperform |
| 2024-03-06 | 開始されました | Barclays | Overweight |
| 2023-07-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-03-28 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
すべてを表示
Elevance Health Inc (ELV) 最新ニュース
Form 144: Ronald Penczek sale of 1,531 ELV shares (ELV) - Stock Titan
Elevance Health (ELV) director reports open-market sale of common stock - Stock Titan
[144] Elevance Health, Inc. SEC Filing - Stock Titan
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Morgan Stanley (MS) issues 300% leveraged PLUS tied to Elevance Health (ELV) stock - Stock Titan
Elevance Health Inc (ELV) Shares Fall 4.7% -- What GF Score of 9 - GuruFocus
Elevance Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Elevance Health Inc Stock (ELV) Moved Down by 5.03% on Jun 10: Facts Behind the Movement - TradingKey
Elevance Health (ELV) Reaffirms 2026 Earnings and Expense Guidan - GuruFocus
Elevance Health (ELV) slides as investors refocus on CMS compliance overhang ahead of key late-June deadline - Quiver Quantitative
Elevance Health Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Elevance Health Reaffirms 2026 Adjusted EPS Guidance - marketscreener.com
(ELV) Elevance Health Expects 2026 Adjusted EPS At Least $26.75, vs. FactSet Est of $26.85 - marketscreener.com
[8-K] Elevance Health, Inc. Reports Material Event - Stock Titan
Elevance Health stock: Is ELV underperforming the health care sector? - MSN
Elevance Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Elevance files lawsuit against former executive for noncompete violation - The Indiana Lawyer
Morgan Stanley (MS) launches 1‑year 300%‑leveraged PLUS on ELV with $1,370.50 cap - Stock Titan
Elevance Health stock hits 52-week high at 422.65 USD By Investing.com - Investing.com Nigeria
Elevance Health stock hits 52-week high at 422.65 USD - Investing.com
Are Wall Street analysts predicting Elevance stock will climb or sink? - MSN
JPMorgan Adjusts Price Target on Elevance Health to $476 From $411, Maintains Overweight Rating - marketscreener.com
ELV Stock Quote Price and Forecast - CNN
Medicare Advantage in 2026: Enrollment Update and Key Trends - KFF
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks - Yahoo Finance
UnitedHealth Stock Jumps 20% YTD: Should Investors Jump in Too? - TradingView
Elevance Health Inc (ELV) Stock Price, Trades & News - GuruFocus
How Investors Are Reacting To Elevance Health (ELV) Expanding Digital Access For Underserved Patients - simplywall.st
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $406.38, Implies 4% Upside - TradingView
UnitedHealth Prescribes Another Dividend Increase: Just a Lighter Dose - TradingView
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $405.19, Implies 4% Upside - TradingView
Chutes & Ladders—Ardent Health appoints new CEO; KFF Founding President, CEO to retire - Fierce Healthcare
Elevance Health’s Digital Equity Push Reframes Virtual Care And Investor Narrative - Yahoo Finance
Collis buys Elevance Health (ELV) shares worth $869,519 By Investing.com - Investing.com Nigeria
Elevance Health Inc (ELV) Shares Fall 3.4% -- What GF Score of 8 - GuruFocus
Elevance Health Inc (ELV) Shares Fall 3.4% -- What GF Score of 89 Tells Investors - GuruFocus
Elevance Health Outperforms Sector Market in Early 2026 - asatunews.co.id
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Collis buys Elevance Health (ELV) shares worth $869,519 - Investing.com
Elevance Health Price Target Raised to $450.00/Share From $375.00 by Truist Securities - Moomoo
Elevance again avoids Medicare Advantage sanctions, but threat remains - Healthcare Dive
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade) (NYSE:ELV) - Seeking Alpha
Elevance Health Stock: Is ELV Underperforming the Health Care Sector? - Barchart
Truist Raises Price Target on Elevance Health to $450 From $375, Keeps Buy Rating - Moomoo
Elevance Health, Inc. (ELV) Stock Analysis: Navigating Growth In The Healthcare Sector - DirectorsTalk Interviews
Elevance Health Secures Spot on Evercore Tactical Outperform List - asatunews.co.id
Elevance Health (ELV): One of the Best Undervalued Stocks to Buy According to the Financial Media - Insider Monkey
Elevance Health gains as Medicare sanctions risk abates - MSN
What Does Elevance Health's Q1 2026 Performance Signal for Investors - Kavout
Elevance Health (ELV) Makes Progress on Medicare Advantage Compl - GuruFocus
Elevance Health Inc (ELV) 財務データ
収益
当期純利益
現金流量
EPS
1.07%
大文字化:
|
ボリューム (24 時間):